Where We Stand
Section: Pharmaceuticals
Policy: Prescription Drug Price Transparency
Prescription Drug Price Transparency
The OMA advocates for a policy that requires disclosure of information relating to the cost and pricing of prescription drugs, to provide accountability to the state and its citizens for prescription drug pricing.
Adopted by the Board of Trustees, February 2018.
Return to the Where We Stand table of contents.